Enhanced production of recombinant serratiopeptidase in Escherichia coli and its characterization as a potential biosimilar to native biotherapeutic counterpart. [electronic resource]
- Microbial cell factories Dec 2019
- 215 p. digital
Publication Type: Journal Article
1475-2859
10.1186/s12934-019-1267-x doi
Biosimilar Pharmaceuticals--metabolism Escherichia coli--enzymology Peptide Hydrolases--biosynthesis Protein Conformation Recombinant Proteins--biosynthesis